Tuesday, November 5, 2024
HomeTagsMai-Jing Liao

Mai-Jing Liao

EGFR TKI H002 From Redcloud Bio Completes First Dose In Non-small Cell Lung Cancer

RedCloud Bio (the "Company"), an innovative biotech company integrating structural pharmacology and computational approaches to advance small molecule drug discovery and development, announced completion...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics